CXS chemgenex pharmaceuticals ltd

Valeant Pharmaceuticals International Inc. , a Canadian pharma...

  1. 27 Posts.
    Valeant Pharmaceuticals International Inc. , a Canadian pharma focused on neurology and dermatology, made a hostile bid to buy Cephalon Inc. for about $5.7 billion, or $73 a share in cash.

    How will this impact the CXS deal??
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.